SANJIVANI PARANTERAL Financial Statement Analysis
|
||
|
The Revenues of SANJIVANI PARANTERAL have increased by 28.83% YoY .
The Earnings Per Share (EPS) of SANJIVANI PARANTERAL has increased by 28.98 % YoY. |
||
SANJIVANI PARANTERAL Last 5 Annual Financial Results
[BOM: 531569]
| Consolidated | Mar2025 | Mar2024 |
|---|---|---|
| Revenues | ₹70 Cr | ₹54 Cr |
| Expenses | ₹60 Cr | ₹46 Cr |
| Operating Profit (Excl OI) | ₹10 Cr | ₹8.02 Cr |
| Other Income | ₹1.29 Cr | ₹0.74 Cr |
| Interest | ₹0.59 Cr | ₹0.25 Cr |
| Depreciation | ₹0.62 Cr | ₹0.93 Cr |
| Profit Before Tax | ₹10 Cr | ₹7.57 Cr |
| Profit After Tax | ₹8.09 Cr | ₹6.17 Cr |
| Consolidated Net Profit | ₹8.10 Cr | ₹6.17 Cr |
| Earnings Per Share (Rs) | ₹6.81 | ₹5.28 |
| PAT Margin (%) | 11.13 | 11.31 |
| ROE(%) | 25.90 | 23.83 |
| ROCE(%) | 29.18 | 27.11 |
| Total Debt/Equity(x) | 0.22 | 0.04 |
Key Financials |
||
| Market Cap | : | ₹ 182.0 Cr |
| Revenue (TTM) | : | ₹ 68.7 Cr |
| Net Profit(TTM) | : | ₹ 6.7 Cr |
| EPS (TTM) | : | ₹ 5.4 |
| P/E (TTM) | : | 27.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SANJIVANI PARANTERAL | 0.6% | -10.9% | -40.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -3.6% | 6% |
| DIVIS LABORATORIES | 1.1% | -1.2% | -0.3% |
| TORRENT PHARMACEUTICALS | 1.6% | 1.4% | 36.7% |
| CIPLA | 0.7% | 2.6% | -4.6% |
| DR REDDYS LABORATORIES | -0.9% | -2.5% | 1.2% |
| MANKIND PHARMA | 0.7% | -1.1% | -4.8% |
| LUPIN | 0.4% | -7.1% | 14.8% |
| ZYDUS LIFESCIENCES | -0.2% | 16% | 16.7% |
SANJIVANI PARANTERAL Revenues
[BOM: 531569]
| Y-o-Y | 28.83 % |
| 5 Yr CAGR | 28.83 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | 28.83 | |
| Mar2024 | ₹54 Cr | - | |
SANJIVANI PARANTERAL Operating Profit
[BOM: 531569]
| Y-o-Y | 28.26 % |
| 5 Yr CAGR | 28.26 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | 28.26 | |
| Mar2024 | ₹8.02 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -0.48 % |
| 5 Yr CAGR | -0.48 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 14.66% | -0.48 | |
| Mar2024 | 14.73% | - | |
SANJIVANI PARANTERAL Profit After Tax
[BOM: 531569]
| Y-o-Y | 31.34 % |
| 5 Yr CAGR | 31.34 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.10 Cr | 31.34 | |
| Mar2024 | ₹6.17 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -1.59 % |
| 5 Yr CAGR | -1.59 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 11.13 % | -1.59 | |
| Mar2024 | 11.31 % | - | |
SANJIVANI PARANTERAL Earnings Per Share (EPS)
[BOM: 531569]
| Y-o-Y | 28.98 % |
| 5 Yr CAGR | 28.98 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.81 | 28.98 | |
| Mar2024 | ₹5.28 | - | |
SANJIVANI PARANTERAL Return on Capital Employed (ROCE)
[BOM: 531569]
| Y-o-Y | 7.64 % |
| 5 Yr CAGR | 7.64 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 29.18% | 7.64 | |
| Mar2024 | 27.11% | - | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Current Share Price | : | ₹148.0 |
| Current MarketCap | : | ₹ 182.0 Cr |
| Updated EOD on | : | Jun 05,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | 0.6% |
-10.9% |
-40.1% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
SANJIVANI PARANTERAL related INDICES
You may also like the below Video Courses
FAQ about SANJIVANI PARANTERAL Financials
How the annual revenues of SANJIVANI PARANTERAL have changed ?
The Revenues of SANJIVANI PARANTERAL have increased by 28.83% YoY .
How the Earnings per Share (EPS) of SANJIVANI PARANTERAL have changed?
The Earnings Per Share (EPS) of SANJIVANI PARANTERAL has increased by 28.98 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs